Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 6/20 | 0.54 |
| ▸ | CA9 | Q16790 | 6/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28918547 | 0.92 | KDM4E (0.54) | MAOAMAOBALDH1A1MAPTKDM4E | |
| SCHEMBL23114203 | 0.88 | MAPT (0.53) | MAOAMAOBALDH1A1MAPTKDM4E | |
| SCHEMBL3057669 | 0.87 | KDM4E (0.63) | MAOAMAOBALDH1A1MAPTKDM4E | |
| SCHEMBL28399285 | 0.76 | MAOB (0.56) | MAOAMAOBALDH1A1MAPTKDM4E | |
| SCHEMBL28122579 | 0.76 | TSHR (0.59) | MAOBALDH1A1MAPTLMNAHPGD | |
| SCHEMBL266607 | 0.75 | CA12 (0.57) | MAOAMAOBALDH1A1MAPTCA12 | |
| SCHEMBL12778676 | 0.75 | MAOB (0.55) | MAOAMAOBALDH1A1MAPTKDM4E | |
| SCHEMBL17199261 | 0.75 | MAOB (0.55) | MAOAMAOBALDH1A1MAPTKDM4E | |
| SCHEMBL5177829 | 0.75 | CA12 (0.57) | MAOAMAOBALDH1A1MAPTKDM4E | |
| SCHEMBL18936062 | 0.75 | MAOB (0.55) | MAOAMAOBALDH1A1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | PLANTVAX, INC. (US) | 2026-02-24 | — | — | US | claimed |
| CN-120165029-A | All-solid-state lithium metal battery and preparation method thereof | 中国科学院上海高等研究院 | 2025-06-17 | — | — | CN | claimed |
| CN-119954760-A | Method for preparing 6-nitrocoumarin by using dynamic tubular reactor | 青岛博纳德机械科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119392325-B | Cyanide-free gold plating solution for plating gold on micro blind holes and electroplating method | 深圳创智芯联科技股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119392325-A | Cyanide-free gold plating solution for plating gold on micro blind holes and electroplating method | 深圳创智芯联科技股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-115155640-B | Molybdenum catalyst, catalytic composition and application thereof in preparation of amine compounds | 海南华瑞医药有限公司 | 2023-09-05 | — | — | CN | claimed |
| WO-2023027630-A9 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-07-27 | — | — | WO | claimed |
| WO-2023027630-A2 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-03-02 | — | — | WO | claimed |
| US-20220062906-A1 | DEVICE FOR DETECTING ORGANOPHOSPHATES | PLANTVAX, INC. (US) | 2022-03-03 | — | — | US | claimed |
| CN-113784801-A | Organic phosphorus detection device | 普兰特瓦可思公司 | 2021-12-10 | — | — | CN | claimed |
| WO-2020227413-A1 | DEVICE FOR DETECTING ORGANOPHOSPHATES | PLANTVAX, INC. (US) | 2020-11-12 | — | — | WO | claimed |
| CN-106946827-B | Preparation method of 6-hydroxycoumarin | 常州佳德医药科技有限公司 | 2020-01-21 | — | — | CN | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| US-20040014804-A1 | Methods for producing amino-substituted chromanes | ELI LILLY AND COMPANY | 2004-01-22 | — | — | US | claimed |
| EP-1286983-A2 | METHODS FOR PRODUCING AMINO-SUBSTITUTED CHROMANES | Eli Lilly & Company (US) | 2003-03-05 | — | — | EP | claimed |
| WO-2001094331-A2 | METHODS FOR PRODUCING AMINO-SUBSTITUTED CHROMANES | ELI LILLY & COMPANY (US) | 2001-12-13 | — | — | WO | claimed |
| WO-1998051307-A1 | METHODS FOR TREATING INFLAMMATION, INFLAMMATORY DISEASES, ARTHRITIS AND STROKE USING pADPRT INHIBITORS | OCTAMER, INC. (US) | 1998-11-19 | — | — | WO | claimed |
| JP-1102530-A | — | — | None | — | — | JP | disclosed |
| US-20260128372-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEMICAL LTD (KR) | 2026-05-07 | — | — | US | disclosed |
| US-12559735-B2 | Device for detecting organophosphates | PLANTVAX, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4576305-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEM, LTD. (KR) | 2025-06-25 | — | — | EP | disclosed |
| CN-120165029-A | All-solid-state lithium metal battery and preparation method thereof | 中国科学院上海高等研究院 | 2025-06-17 | — | — | CN | disclosed |
| CN-120153509-A | Nonaqueous electrolyte for lithium secondary battery and lithium secondary battery comprising same | 株式会社LG化学 | 2025-06-13 | — | — | CN | disclosed |
| CN-119954760-A | Method for preparing 6-nitrocoumarin by using dynamic tubular reactor | 青岛博纳德机械科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119954760-A | Method for preparing 6-nitrocoumarin by using dynamic tubular reactor | 青岛博纳德机械科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119954760-A | Method for preparing 6-nitrocoumarin by using dynamic tubular reactor | 青岛博纳德机械科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119392325-B | Cyanide-free gold plating solution for plating gold on micro blind holes and electroplating method | 深圳创智芯联科技股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119528828-A | Synthesis method of methylation product of nitrogen heterocycle or oxygen heterocycle compound | 桂林理工大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-119392325-A | Cyanide-free gold plating solution for plating gold on micro blind holes and electroplating method | 深圳创智芯联科技股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-118126009-A | Coumarin derivative, preparation method and application | 成都纽瑞特医疗科技股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117720495-A | Preparation method of novel amide-containing coumarin derivative, antibacterial effect of composition and application of composition in aspect of promoting plant growth | 贵州工业职业技术学院 | 2024-03-19 | — | — | CN | disclosed |
| CN-115594602-B | Method for synthesizing aromatic amine by visible light induction | 南京大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-114560837-B | Chromone compound and preparation method and application thereof | 五邑大学 | 2023-11-24 | — | — | CN | disclosed |
| US-20230277505-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2023-09-07 | — | — | US | disclosed |
| CN-115155640-B | Molybdenum catalyst, catalytic composition and application thereof in preparation of amine compounds | 海南华瑞医药有限公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023027630-A9 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-07-27 | — | — | WO | disclosed |
| CN-116178256-B | Medicinal compound taking STING as target point, and preparation method and application thereof | 烟台大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-112552272-B | Coumarin compound, preparation method and application thereof, and pharmaceutical composition | 四川大学 | 2023-06-27 | — | — | CN | disclosed |
| CN-116178256-A | Medicinal compound taking STING as target point, and preparation method and application thereof | 烟台大学 | 2023-05-30 | — | — | CN | disclosed |
| US-11655203-B2 | Nitration | ETH ZURICH (CH) | 2023-05-23 | — | — | US | disclosed |
| WO-2023027630-A2 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-03-02 | — | — | WO | disclosed |
| CN-115594602-A | Visible light induced method for synthesizing aromatic amine | 南京大学（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-109456308-B | Heterocyclic compounds as ASK inhibitors and their use | 南京圣和药业股份有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-115155640-A | Molybdenum catalyst, catalytic composition and application of catalytic composition in preparation of amine compounds | 海南华瑞医药有限公司 | 2022-10-11 | — | — | CN | disclosed |
| WO-2022135072-A1 | COUMARIN COMPOUND, PREPARATION METHOD THEREFOR, AND USE AND PHARMACEUTICAL COMPOSITION THEREOF | 四川大学 | 2022-06-30 | — | — | WO | disclosed |
| CN-114560837-A | Chromone compound and preparation method and application thereof | 五邑大学 | 2022-05-31 | — | — | CN | disclosed |
| CN-109053660-B | Compound containing trifluoromethylthio coumarin, and synthetic method and application thereof | 青岛农业大学 | 2022-04-26 | — | — | CN | disclosed |
| US-20220062906-A1 | DEVICE FOR DETECTING ORGANOPHOSPHATES | PLANTVAX, INC. (US) | 2022-03-03 | — | — | US | disclosed |
| CN-113784801-A | Organic phosphorus detection device | 普兰特瓦可思公司 | 2021-12-10 | — | — | CN | disclosed |
| CN-111848451-B | Preparation method of cyano compound | 中国科学院化学研究所 | 2021-08-24 | — | — | CN | disclosed |
| CN-110105319-B | Preparation method of C-3 alkyl substituted coumarin derivative | 浙江工业大学 | 2021-05-04 | — | — | CN | disclosed |
| CN-110483460-B | Preparation method of 3-seleno-coumarin compound | 温州医科大学 | 2021-04-20 | — | — | CN | disclosed |
| CN-112552272-A | Coumarin compound, preparation method and application thereof, and pharmaceutical composition | 四川大学 | 2021-03-26 | — | — | CN | disclosed |
| CN-107674052-B | Synthesis method of vilazodone intermediate 5- (1-piperazinyl) -2-benzofuran-2-carboxylic acid ethyl ester | 连云港恒运药业有限公司 | 2021-03-05 | — | — | CN | disclosed |
| CN-107674052-B | Synthesis method of vilazodone intermediate 5- (1-piperazinyl) -2-benzofuran-2-carboxylic acid ethyl ester | 连云港恒运药业有限公司 | 2021-03-05 | — | — | CN | disclosed |
| US-20200397755-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2020-12-24 | — | — | US | disclosed |
| CN-107540646-B | Synthesis method of vilazodone intermediate | 连云港恒运药业有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-107540646-B | Synthesis method of vilazodone intermediate | 连云港恒运药业有限公司 | 2020-12-01 | — | — | CN | disclosed |
| WO-2020227413-A1 | DEVICE FOR DETECTING ORGANOPHOSPHATES | PLANTVAX, INC. (US) | 2020-11-12 | — | — | WO | disclosed |
| CN-111848451-A | Preparation method of cyano compound | 中国科学院化学研究所 | 2020-10-30 | — | — | CN | disclosed |
| US-10781180-B2 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2020-09-22 | — | — | US | disclosed |
| CN-106946827-B | Preparation method of 6-hydroxycoumarin | 常州佳德医药科技有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-106946827-B | Preparation method of 6-hydroxycoumarin | 常州佳德医药科技有限公司 | 2020-01-21 | — | — | CN | disclosed |
| US-20190263757-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2019-08-29 | — | — | US | disclosed |
| CN-109456308-A | Heterocyclic compound and its application as ASK inhibitor | 南京圣和药业股份有限公司 | 2019-03-12 | — | — | CN | disclosed |
| CN-109053660-A | Coumarin kind compound containing trifluoromethylthio, its synthetic method and its application | 青岛农业大学 | 2018-12-21 | — | — | CN | disclosed |
| US-20180169070-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2018-06-21 | — | — | US | disclosed |
| CN-107674052-A | Vilazodone intermediate 5（1 piperazinyl）The carboxylic acid, ethyl ester synthetic method of 2 benzofuran 2 | 连云港恒运药业有限公司 | 2018-02-09 | — | — | CN | disclosed |
| CN-107540646-A | Vilazodone intermediate synthetic method | 连云港恒运药业有限公司 | 2018-01-05 | — | — | CN | disclosed |
| US-9775829-B2 | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2017-10-03 | — | — | US | disclosed |
| CN-104974121-B | A kind of synthetic method of 3 sweet-smelling formacyl coumarin derivative | 河南工业大学 | 2017-03-15 | — | — | CN | disclosed |
| CN-105037428-B | Preparation method for coumarin-3-phosphonate derivative | 河南工业大学 | 2017-01-25 | — | — | CN | disclosed |
| US-20160374990-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2016-12-29 | — | — | US | disclosed |
| US-20160304463-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2016-10-20 | — | — | US | disclosed |
| CN-106008434-A | Synthetic method for 3-benzoyl coumarin compound | 青岛农业大学 | 2016-10-12 | — | — | CN | disclosed |
| CN-104230728-B | 1,2-diketone naphthalene compounds and preparation method and application | 山东大学 | 2016-08-24 | — | — | CN | disclosed |
| US-9273035-B2 | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| WO-2016022915-A1 | 6-SULFONYLAMINO QUINOLINE COMPOUNDS AS PLANT GROWTH REGULATORS | THE REGENT OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-02-11 | — | — | WO | disclosed |
| US-20150307538-A1 | USE OF THERMALLY-TREATED SUPPORTED COBALT CATALYSTS COMPRISING A POLYCYCLIC AROMATIC STRUCTURE CONSISTING OF NITROGEN LIGANDS FOR HYROGENATING AROMATIC NITRO COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2015-10-29 | — | — | US | disclosed |
| US-20150307538-A1 | USE OF THERMALLY-TREATED SUPPORTED COBALT CATALYSTS COMPRISING A POLYCYCLIC AROMATIC STRUCTURE CONSISTING OF NITROGEN LIGANDS FOR HYROGENATING AROMATIC NITRO COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2015-10-29 | — | — | US | disclosed |
| CN-103554074-B | Preparation method of 3-trifluoromethyl coumarin derivative | UNIV SOOCHOW | 2015-03-25 | — | — | CN | disclosed |
| US-20150073141-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2015-03-12 | — | — | US | disclosed |
| US-8871797-B2 | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| US-8785441-B2 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2014-07-22 | — | — | US | disclosed |
| US-8754238-B2 | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2014-06-17 | — | — | US | disclosed |
| CN-103554074-A | Preparation method of 3-trifluoromethyl coumarin derivative | UNIV SOOCHOW | 2014-02-05 | — | — | CN | disclosed |
| US-20130237541-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2013-09-12 | — | — | US | disclosed |
| US-20130237540-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2013-09-12 | — | — | US | disclosed |
| CN-103012378-A | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto | ARENA PHARM INC | 2013-04-03 | — | — | CN | disclosed |
| CN-102977029-A | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | ARENA PHARM INC | 2013-03-20 | — | — | CN | disclosed |
| CN-101084195-B | As 5-HT2A3-phenyl-pyrazole derivatives useful as serotonin receptor modulators for the treatment of disorders related thereto | ARENA PHARM INC | 2013-01-02 | — | — | CN | disclosed |
| CN-101497632-B | Method for synthesizing coumarin-3-phosphonate derivative | UNIV SOOCHOW | 2012-01-25 | — | — | CN | disclosed |
| US-20110105456-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2011-05-05 | — | — | US | disclosed |
| US-7884101-B2 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2011-02-08 | — | — | US | disclosed |
| EP-2211854-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER USING BENZOPYRONE-TYPE PARP INHIBITORS | BiPar Sciences, Inc. (US) | 2010-08-04 | — | — | EP | disclosed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| CN-101497632-A | Method for synthesizing coumarin-3-phosphonate derivative | UNIV SOOCHOW (CN) | 2009-08-05 | — | — | CN | disclosed |
| US-20090149417-A1 | Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors | BIPAR SCIENCES, INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090149417-A1 | Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors | BIPAR SCIENCES, INC. | 2009-06-11 | — | — | US | disclosed |
| EP-2059802-A2 | METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF | Bipar Sciences, Inc. (US) | 2009-05-20 | — | — | EP | disclosed |
| WO-2009051815-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER USING BENZOPYRONE-TYPE PARP INHIBITORS | BIPAR SCIENCES, INC. (US) | 2009-04-23 | — | — | WO | disclosed |
| EP-1978019-A1 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2008-10-08 | — | — | EP | disclosed |
| EP-1833799-B1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2008-09-10 | — | — | EP | disclosed |
| US-20080076778-A1 | METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF | BIPAR SCIENCES, INC. (US) | 2008-03-27 | — | — | US | disclosed |
| US-20080076778-A1 | METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF | BIPAR SCIENCES, INC. (US) | 2008-03-27 | — | — | US | disclosed |
| WO-2008030887-A2 | METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF | BIPAR SCIENCES, INC. (US) | 2008-03-13 | — | — | WO | disclosed |
| WO-2008030887-A2 | METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF | BIPAR SCIENCES, INC. (US) | 2008-03-13 | — | — | WO | disclosed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | disclosed |
| US-20070244086-A1 | 3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto | ARENA PHARMACEUTICALS, INC. | 2007-10-18 | — | — | US | disclosed |
| EP-1833799-A2 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2007-09-19 | — | — | EP | disclosed |
| US-20070207994-A1 | 3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. | 2007-09-06 | — | — | US | disclosed |
| US-20070078134-A1 | Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot | ARENA PHARMACEUTICALS (US) | 2007-04-05 | — | — | US | disclosed |
| US-20070072857-A1 | Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot | ARENA PHARMACEUTICALS (US) | 2007-03-29 | — | — | US | disclosed |
| US-20060211636-A1 | Macrolide Antibiotics | ALIHODZIC SULEJMAN | 2006-09-21 | — | — | US | disclosed |
| EP-1695966-A1 | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2006-08-30 | — | — | EP | disclosed |
| WO-2006055734-A2 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| EP-1558582-B1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2005-12-21 | — | — | EP | disclosed |
| US-20050215495-A1 | Macrolide antibiotics | ALIHODZIC SULEJMAN | 2005-09-29 | — | — | US | disclosed |
| EP-1558582-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2005-08-03 | — | — | EP | disclosed |
| US-6903227-B2 | Synthesis of 2-acyl substituted chromanes and intermediates thereof | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-06-07 | — | — | US | disclosed |
| US-20050080124-A1 | Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot | ARENA PHARMACEUTIALS, INC. | 2005-04-14 | — | — | US | disclosed |
| WO-2005012254-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERTO | ARENA PHARMACEUTICALS, INC. (US) | 2005-02-10 | — | — | WO | disclosed |
| US-6831199-B1 | In order to avoid bleeding side-effects when treating the conditions associated with integrin alpha v beta 3, it is beneficial to have compounds which are selective antagonists for alpha v beta 3 versus alpha IIb beta 3 | G. D. SEARLE & CO. | 2004-12-14 | — | — | US | disclosed |
| US-6756403-B2 | 6-AMINOCHROMAN-2-YL CARBOXYLIC ACIDS AND ESTERS AS PLATELET AGGREGATION INHIBITORS; FROM PHENOL AND KETOGLUTARIC ACID; OR FROM 2-HYDROXYACETOPHENONE AND DIETHYLOXALATE; OR FROM NITROPHENOL AND DIETHYL ESTER OF MALEIC ACID | ELI LILLY AND COMPANY | 2004-06-29 | — | — | US | disclosed |
| US-20040053992-A1 | Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor | ELI LILLY AND COMPANY | 2004-03-18 | — | — | US | disclosed |
| US-20040014804-A1 | Methods for producing amino-substituted chromanes | ELI LILLY AND COMPANY | 2004-01-22 | — | — | US | disclosed |
| US-20030233002-A1 | Synthesis of 2-Acyl substituted chromanes and intermediates thereof | MILLENNIUM PHARMACEUTICALS, INC. | 2003-12-18 | — | — | US | disclosed |
| US-20030130342-A1 | Glycoprotein llb/llla antagonists | FISHER MATTHEW J (US) | 2003-07-10 | — | — | US | disclosed |
| EP-1292589-A2 | METHODS FOR PRODUCING CHIRAL CHROMONES, CHROMANES, AMINO SUBSTITUTED CHROMANES AND INTERMEDIATES THEREFOR | MILLENIUM PHARMACEUTICALS, INC. (US) | 2003-03-19 | — | — | EP | disclosed |
| EP-1286983-A2 | METHODS FOR PRODUCING AMINO-SUBSTITUTED CHROMANES | Eli Lilly & Company (US) | 2003-03-05 | — | — | EP | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| EP-0804431-B9 | GLYCOPROTEIN IIb/IIIa ANTAGONISTS | LILLY CO ELI (US) | 2003-01-02 | — | — | EP | disclosed |
| US-6448269-B1 | SUCH AS 6-(N-(4-(AMINOIMINOMETHYL)BENZOYL)AMINO)-3,4-DIHYDRO-4,4-DIMETHYL-2H-1 -BENZOPYRAN-2-YL)ACETIC ACID; INHIBITING PLATELET AGGREGATION OR FIBRINOGEN BINDING OR PREVENTING THROMBOSIS | ELI LILLY AND COMPANY | 2002-09-10 | — | — | US | disclosed |
| EP-0804431-B1 | GLYCOPROTEIN IIb/IIIa ANTAGONISTS | LILLY CO ELI (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001094335-A2 | METHODS FOR PRODUCING CHIRAL CHROMONES, CHROMANES, AMINO SUBSTITUTED CHROMANES AND INTERMEDIATES THEREFOR | ELI LILLY & COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001094331-A2 | METHODS FOR PRODUCING AMINO-SUBSTITUTED CHROMANES | ELI LILLY & COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001092250-A2 | SYNTHESIS OF 2-ACYL SUBSTITUTED CHROMANES AND INTERMEDIATES THEREOF | COR THERAPEUTICS, INC. (US) | 2001-12-06 | — | — | WO | disclosed |
| US-6306587-B1 | APPARATUS OF VESSEL FOR RECEIVING SAMPLE AND TWO PROBES, EACH HAVING FUNCTIONAL GROUPS CAPABLE OF REACTING WITH EACH OTHER TO FORM COVALENT BOND; LIGHT SOURCE TO ACTIVATE GROUPS; AND DETECTOR TO DETECT REACTION PRODUCT | VYSIS, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-0850221-B1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | SEARLE & CO (US) | 2001-07-18 | — | — | EP | disclosed |
| US-6028223-A | AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | disclosed |
| US-6020362-A | ANTICOAGULANTS | ELI LILLY AND COMPANY (US) | 2000-02-01 | — | — | US | disclosed |
| US-5783599-A | ADMINISTERING SELECTIVE, NONTOXIC CYTOSTATIC AND ANTIVIRAL AGENTS | OCTAMER, INC. | 1998-07-21 | — | — | US | disclosed |
| EP-0850221-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1998-07-01 | — | — | EP | disclosed |
| EP-0804431-A4 | GLYCOPROTEIN IIb/IIIa ANTAGONISTS | LILLY CO ELI (US) | 1998-04-29 | — | — | EP | disclosed |
| US-5731324-A | Glycoprotein IIb/IIIa antagonists | ELI LILLY AND COMPANY (US) | 1998-03-24 | — | — | US | disclosed |
| US-5686243-A | DETECTING POLYNUCLEOTIDE SEQUENCES; HYBRIDIZATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0804431-A1 | GLYCOPROTEIN IIb/IIIa ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1997008145-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1997-03-06 | — | — | WO | disclosed |
| US-5583155-A | VIRICIDES; POTENTIATION | OCTAMER, INC. (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0553248-B1 | NOVEL 5-IODO-6-AMINO-1,2-BENZOPYRONES AND THEIR ANALOGS USEFUL AS CYTOSTATIC AND ANTIVIRAL AGENTS | OCTAMER INC (US) | 1996-09-18 | — | — | EP | disclosed |
| WO-1996022288-A1 | GLYCOPROTEIN IIb/IIIa ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1996-07-25 | — | — | WO | disclosed |
| US-5519053-A | ANTICARCINOGENIC AGENTS, VIRICIDES | OCTAMER, INC. (US) | 1996-05-21 | — | — | US | disclosed |
| US-5484951-A | TREATMENT OF AIDS, HERPES, CYTOMEGALO VIRUS, ANTITUMOR AGENTS | OCTAMER, INCORPORATED (US) | 1996-01-16 | — | — | US | disclosed |
| US-5464871-A | Aromatic amides | OCTAMER, INC. (US) | 1995-11-07 | — | — | US | disclosed |
| US-5449602-A | Polynucleotides | AMOCO CORPORATION (US) | 1995-09-12 | — | — | US | disclosed |
| EP-0666742-A1 | ADENOSINE DIPHOSPHORIBOSE POLYMERASE BINDING NITROSO AROMATIC COMPOUNDS USEFUL AS ANTI-RETROVIRAL AGENTS AND ANTI-TUMOR AGENTS | OCTAMER, INC. (US) | 1995-08-16 | — | — | EP | disclosed |
| EP-0324616-B1 | Template-directed photoligation | AMOCO CORP (US) | 1995-03-29 | — | — | EP | disclosed |
| US-5376679-A | Fungicides, bactericides, nematocides | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1994-12-27 | — | — | US | disclosed |
| WO-1994009776-A1 | ADENOSINE DIPHOSPHORIBOSE POLYMERASE BINDING NITROSO AROMATIC COMPOUNDS USEFUL AS ANTI-RETROVIRAL AGENTS AND ANTI-TUMOR AGENTS | OCTAMER, INC. (US) | 1994-05-11 | — | — | WO | disclosed |
| CN-1023957-C | Pesticide compound | SHELL INT RESEARCH (NL) | 1994-03-16 | — | — | CN | disclosed |
| US-5271927-A | Antibody conjugates with macrocyclic ligands | CELLTECH LIMITED (GB) | 1993-12-21 | — | — | US | disclosed |
| EP-0553248-A1 | NOVEL 5-IODO-6-AMINO-1,2-BENZOPYRONES AND THEIR ANALOGS USEFUL AS CYTOSTATIC AND ANTIVIRAL AGENTS. | UNIV CALIFORNIA (US) | 1993-08-04 | — | — | EP | disclosed |
| EP-0371560-B1 | BIOCIDAL AROMATIC AZOCARBOXYLIC-ACID DERIVATIVES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-05-05 | — | — | EP | disclosed |
| EP-0494231-A4 | 6-AMINO-1,2-BENZOPYRONES USEFUL FOR TREATMENT OF VIRAL DISEASES | — | 1992-09-16 | — | — | EP | disclosed |
| EP-0494231-A1 | 6-AMINO-1,2-BENZOPYRONES USEFUL FOR TREATMENT OF VIRAL DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1992-07-15 | — | — | EP | disclosed |
| WO-1992006687-A1 | NOVEL 5-IODO-6-AMINO-1,2-BENZOPYRONES AND THEIR ANALOGS USEFUL AS CYTOSTATIC AND ANTIVIRAL AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1992-04-30 | — | — | WO | disclosed |
| US-5087696-A | CONJUGATE COMPOUND | CELLTECH LIMITED (GB) | 1992-02-11 | — | — | US | disclosed |
| EP-0238196-B1 | CONJUGATE COMPOUND COMPRISING A MACROCYCLIC LIGAND AND AN ANTIBODY | CELLTECH LIMITED (GB) | 1991-09-25 | — | — | EP | disclosed |
| WO-1991004663-A1 | 6-AMINO-1,2-BENZOPYRONES USEFUL FOR TREATMENT OF VIRAL DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-04-18 | — | — | WO | disclosed |
| EP-0371560-A2 | Biocidal aromatic azocarboxylic-acid derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1990-06-06 | — | — | EP | disclosed |
| EP-0324616-A2 | Template-directed photoligation | AMOCO CORPORATION (US) | 1989-07-19 | — | — | EP | disclosed |
| JP-H01102530-A | ORGANIC NONLINEAR OPTICAL ELEMENT | HITACHI LTD | 1989-04-20 | — | — | JP | disclosed |
| EP-0238196-A1 | Conjugate compound comprising a macrocyclic ligand and an antibody | CELLTECH LIMITED (GB) | 1987-09-23 | — | — | EP | disclosed |
| WO-1987005030-A1 | CONJUGATE COMPOUND | CELLTECH LIMITED (GB) | 1987-08-27 | — | — | WO | disclosed |
| WO-1987005030-A1 | CONJUGATE COMPOUND | CELLTECH LIMITED (GB) | 1987-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (28 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180169070-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR2A, HTR2C | MAOA 34/4885MAOB 33/4885ALDH1A1 936/4885 |
| US-20200397755-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR2A, HTR2C | MAOA 34/4885MAOB 33/4885ALDH1A1 936/4885 |
| US-20090149417-A1 | Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors | PARP1, PARP2, PARP3 | MAOA 1244/4885MAOB 802/4885ALDH1A1 674/4885 |
| US-20130237540-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR3A, HTR3B | MAOA 96/4885MAOB 78/4885ALDH1A1 1557/4885 |
| US-20030233002-A1 | Synthesis of 2-Acyl substituted chromanes and intermediates thereof | PLA2G7, PAFAH1B2, PAFAH1B3 | MAOA 303/4885MAOB 412/4885ALDH1A1 773/4885 |
| US-20050080124-A1 | Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot | HTR2C, HTR2A, HTR5A | MAOA 185/4885MAOB 58/4885ALDH1A1 1648/4885 |
| US-20050215495-A1 | Macrolide antibiotics | IL1R1, MRPL12, RPS21 | MAOA 4469/4885MAOB 3949/4885ALDH1A1 2549/4885 |
| US-20080076778-A1 | METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF | PARP3, PARP1, PARP15 | MAOA 1533/4885MAOB 1011/4885ALDH1A1 1787/4885 |
| US-20040014804-A1 | Methods for producing amino-substituted chromanes | PFKP, TBXAS1, TBXA2R | MAOA 252/4885MAOB 510/4885ALDH1A1 899/4885 |
| US-20160304463-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR3A, HTR2A | MAOA 72/4885MAOB 53/4885ALDH1A1 2174/4885 |
| US-20070207994-A1 | 3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto | HTR5A, HTR3A, HTR3B | MAOA 96/4885MAOB 78/4885ALDH1A1 1557/4885 |
| US-12559735-B2 | Device for detecting organophosphates | BCHE, LIPE, ACHE | MAOA 537/4885MAOB 772/4885ALDH1A1 1082/4885 |
| US-20070078134-A1 | Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot | HTR2C, HTR2A, HTR5A | MAOA 185/4885MAOB 58/4885ALDH1A1 1648/4885 |
| US-20070072857-A1 | Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot | HTR2C, HTR2A, HTR5A | MAOA 185/4885MAOB 58/4885ALDH1A1 1648/4885 |
| US-20130237541-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR2A, HTR2C | MAOA 51/4885MAOB 47/4885ALDH1A1 731/4885 |
| US-20060211636-A1 | Macrolide Antibiotics | IL1R1, MRPL12, RPS21 | MAOA 4469/4885MAOB 3949/4885ALDH1A1 2549/4885 |
| US-20260128372-A1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | CLCN2, CLIC1, RER1 | MAOA 3043/4885MAOB 1988/4885ALDH1A1 721/4885 |
| US-20190263757-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR3A, HTR2A | MAOA 72/4885MAOB 53/4885ALDH1A1 2174/4885 |
| US-20040053992-A1 | Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor | NOTUM, FAR1, CYP51A1 | MAOA 914/4885MAOB 1458/4885ALDH1A1 869/4885 |
| US-20110105456-A1 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR3A, HTR3B | MAOA 96/4885MAOB 78/4885ALDH1A1 1557/4885 |
| US-20160374990-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR2A, HTR2C | MAOA 51/4885MAOB 47/4885ALDH1A1 740/4885 |
| US-20150073141-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR2A, HTR2C | MAOA 51/4885MAOB 47/4885ALDH1A1 731/4885 |
| US-20150307538-A1 | USE OF THERMALLY-TREATED SUPPORTED COBALT CATALYSTS COMPRISING A POLYCYCLIC AROMATIC STRUCTURE CONSISTING OF NITROGEN LIGANDS FOR HYROGENATING AROMATIC NITRO COMPOUNDS | NUP188, NUP50, NUCB2 | MAOA 135/4885MAOB 183/4885ALDH1A1 2978/4885 |
| US-10781180-B2 | 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | HTR5A, HTR3A, HTR2A | MAOA 72/4885MAOB 53/4885ALDH1A1 2174/4885 |
| US-20070244086-A1 | 3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto | HTR5A, HTR3A, HTR2A | MAOA 72/4885MAOB 53/4885ALDH1A1 2174/4885 |
| US-20230277505-A1 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | HTR5A, HTR2A, HTR2C | MAOA 34/4885MAOB 33/4885ALDH1A1 936/4885 |
| US-20030130342-A1 | Glycoprotein llb/llla antagonists | SELL, SELPLG, LY96 | MAOA 3726/4885MAOB 2042/4885ALDH1A1 1693/4885 |
| US-11655203-B2 | Nitration | NOS1, NOS2, NOS3 | MAOA 112/4885MAOB 206/4885ALDH1A1 2335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.